NCT00001826View on ClinicalTrials.gov

Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor

CompletedOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

July 31, 1999

Study Completion Date

May 31, 2006

Conditions

HIV Infection

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00001826 - Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor | Biotech Hunter | Biotech Hunter